Company: HCTI
Filing Date: 2025-10-16
Form Type: S-3
Source: 0001213900-25-099533
Chunk: 27

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-16
Form: S-3
Chunk 27
---
 Warrants, see “Warrant Inducement Private Placement” above. We are registering the shares of Common Stock in order to permit the Selling Stockholders to offer
the shares of Common Stock for resale from time to time.

The table below lists the Selling Stockholders
and provides information regarding their beneficial ownership of shares of Common Stock by each of the Selling Stockholders. The second
column lists the number of shares of Common Stock beneficially owned by the Selling Stockholders, based on their ownership of the shares
of Common Stock, the Common Warrants and shares of Common Stock issuable upon exercise of warrants acquired in offerings prior to the
transactions described in the section entitled, “Warrant Inducement Private Placement,” as of October 15, 2025, assuming
exercise of the Common Warrants held by the Selling Stockholders on that date, without regard to any limitations on exercises. The third
column lists the maximum number of shares of Common Stock being offered by this prospectus by the Selling Stockholders, also without regard
to any limitations on exercises.

In accordance with the terms of the Inducement
Agreement, this prospectus generally covers the resale of the maximum number of shares of Common Stock issuable upon exercise of the Common
Warrants, determined as if the outstanding Common Warrants were exercised in full as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of
determination and all subject to adjustment as provided in the Inducement Agreement and Common Warrants, without regard to any limitations
on the exercise of the Common Warrants. The fourth column assume the sale of all of the shares offered by the Selling Stockholders pursuant
to this prospectus.

Under the terms of the Common Warrants, the Selling
Stockholders may not exercise the Common Warrants to the extent such exercise would cause such Selling Stockholder, together with its
affiliates and attribution parties, to beneficially own a number of shares of Common Stock that would exceed 4.99%, of our then-outstanding
Common Stock following such exercise, excluding for purposes of such determination shares of Common Stock issuable upon exercise of such
warrants which have not been exercised. The number of shares in the second, third and fourth columns do not reflect this limitation. The
Selling Stockholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”

| Name of Selling Stockholder